Kate Haviland - CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer
Stock Symbol
BPMC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kate Haviland - trading volume in the past year for Blueprint Medicines Corp

Holdings reported by Kate Haviland for Blueprint Medicines Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 153K $13.9M $90.69 Mar 7, 2024 Direct
Stock Option (Right to Buy) 80K Mar 1, 2024 Direct Common Stock

Transactions reported by Kate Haviland for Blueprint Medicines Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.